NG males | HSV-2 females | |||||
---|---|---|---|---|---|---|
Observed prevalence (%) | Rakai 0.93 | Masaka 0.80 | Mwanza 2.05 | Rakai 41.9 | Masaka 44.1 | Mwanza 46.8 |
Highlighted values correspond to values from table 3. Se = sensitivity, Sp = specificity, Se′ = sensitivity of screening test, pscreen = prevalence of positive screening test, UL = upper limit, LL = lower limit, na= not applicable. | ||||||
Prevalence after adjustment for: | ||||||
Se alone | 1.05 | 0.90 | 2.46 | 45.5 | 48.5 | 51.4 |
Sp alone | 0.93 | 0.80 | 2.05 | 41.9 | 39.9 | 42.8 |
Se + Sp | 1.05 | 0.90 | 2.46 | 45.5 | 44.2 | 47.4 |
Se′ alone | na | na | 2.34 | na | na | na |
Se′ UL alone | na | na | 2.16 | na | na | na |
Se′ LL alone | na | na | 4.66 | na | na | na |
Se+Sp+Se′ | na | na | 2.81 | na | na | na |
Se+Sp+Se′UL | na | na | 2.59 | na | na | na |
Se+Sp+Se′LL | na | na | 5.59 | na | na | na |
Selection bias UL | na | na | na | 39.4 | na | na |
Selection bias | na | na | na | 36.9 | na | na |
Se+Sp+selection bias UL | na | na | na | 44.2 | na | na |
Se+Sp+selection bias | na | na | na | 42.8 | na | na |